Shares of Amneal Pharmaceuticals (AMRX) have gained 22.1% over the past four weeks to close the last trading session at $9.56, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$12 indicates a potential upside of 25.5%.The mean estimate comprises four short-term price targets with a standard deviation of $0.82. While the lowest estimate of$11.00 indicates a 15.1% increase from th ...